#DeathCross $UCO at 16.62 R18 HiLo 1% DIV N/A #ProShares #stocks #trading #finance #market

2018-11-29
49 Views

Death Cross detected for UCO (ProShares Ultra Bloo) at the close price of 16.62. Trading at a 1 % level between the 52week High (39.36) and 52week Low (16.39).
The average analyst 1-year target price is 0.0 with an average and a score of 0.0.

Death Cross 18 % UCO 16.62
ProShares Ultra Bloo HiLo 1.0 pc
Support 16.62 Resistance 21.79
50DMA 29.20 200DMA 29.32
52week high 39.36 52week low 16.39
10DMA 19.30 20DMA 22.23
100 Mean 29.91
Volume 8107971 AvgDayVol 2790050
MarketCap 0 EBITDA 0
Revenue 0 PE 0.00
P2S 0.00 P2B 0.00
Dividend 0.00 Div Ex-Date 1970-01-31 00:00:00

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

Demark B/S Index 5.2 Avg 29.91 Std 0 Curr #stocks #trading #markets #finance
Global Indicators,
26 views
Global Indicators,
26 views

Demark B/S Index 5.2 Avg 29.91 Std 0 Curr #stocks #trading #markets #finance

Andreas Aigner - 2018-12-15

Demark B/S Index 5.2 Avg 29.91 Std 0 Curr #stocks #trading #markets #finance

50/200 DMA Index -2.02 Avg 6.18 Std -10 Curr #stocks #trading #markets #finance
Bear, Global Indicators
33 views
Bear, Global Indicators
33 views

50/200 DMA Index -2.02 Avg 6.18 Std -10 Curr #stocks #trading #markets #finance

Andreas Aigner - 2018-12-15

[Bearish] 50/200 DMA Index -2.02 Avg 6.18 Std -10 Curr #stocks #trading #markets #finance x

#DeathCross $XBIO at 2.57 R21  HiLo 16% T1Y 10 strong_buy 1.0 fwdPE -2.2 DIV N/A #Xenetic Bi #stocks #trading #finance #market
Bear, Healthcare, Single UL Indicators
39 views
Bear, Healthcare, Single UL Indicators
39 views

#DeathCross $XBIO at 2.57 R21 HiLo 16% T1Y 10 strong_buy 1.0 fwdPE -2.2 DIV N/A #Xenetic Bi #stocks #trading #finance #market

Andreas Aigner - 2018-12-15

Death Cross detected for XBIO (Xenetic Biosciences,) at the close price of 2.57. Trading at a 16 % level between…

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.